4d Molecular Therapeutics Inc's Comment on Supply Chain
The company depends on third-party suppliers for key raw materials used in manufacturing its product candidates, including biologically derived substances such as plasmids. These materials are challenging to procure and may be subject to contamination, recall, or restrictions, potentially disrupting commercial manufacturing or clinical production. The company faces risks related to supplier pricing, availability, quality, and delivery schedules, with limited negotiation leverage due to its small size. Any supplier interruption or failure could delay development, clinical trials, regulatory approvals, and commercialization. The company may also encounter difficulties in securing alternative suppliers on reasonable terms within a timely manner.
4d Molecular Therapeutics Inc's Comment on Supply Chain
The company depends on third-party suppliers for key raw materials used in manufacturing its product candidates, including biologically derived substances such as plasmids. These materials are challenging to procure and may be subject to contamination, recall, or restrictions, potentially disrupting commercial manufacturing or clinical production. The company faces risks related to supplier pricing, availability, quality, and delivery schedules, with limited negotiation leverage due to its small size. Any supplier interruption or failure could delay development, clinical trials, regulatory approvals, and commercialization. The company may also encounter difficulties in securing alternative suppliers on reasonable terms within a timely manner.
Sources:
4d Molecular Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on 4d Molecular Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
